Koers Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Aandelen
688076
CNE1000051X5
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
55,23 CNY | +2,87% | +6,72% | +22,87% |
Omzet 2024 * | 1,49 mld. 205 mln. 192 mln. | Omzet 2025 * | 1,97 mld. 272 mln. 254 mln. | Marktkapitalisatie | 11,45 mld. 1,58 mld. 1,48 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 234 mln. 32,3 mln. 30,17 mln. | Nettowinst (verlies) 2025 * | 325 mln. 44,86 mln. 41,91 mln. | EV/omzet 2024 * | 7,7 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 5,8 x |
K/w-verhouding 2024 * |
49,1
x | K/w-verhouding 2025 * |
35,2
x | Werknemers | 1.545 |
Dividendrendement 2024 * |
0,56% | Dividendrendement 2025 * |
0,87% | Vrij verhandelbaar | 52,6% |
1 dag | +2,87% | ||
1 week | +6,72% | ||
Lopende maand | +4,48% | ||
1 maand | -3,34% | ||
3 maanden | +43,34% | ||
6 maanden | +34,84% | ||
Lopend jaar | +22,87% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zi Quan Tong
CEO | Chief Executive Officer | 54 | 01-09-17 |
Wei Ding
DFI | Director of Finance/CFO | 41 | 06-02-23 |
Biao Liu
CHM | Chairman | 43 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qiang Guo Xu
BRD | Director/Board Member | 60 | 20-05-19 |
Feng Qu
BRD | Director/Board Member | 49 | 20-05-19 |
De Yi Zhao
BRD | Director/Board Member | 61 | 03-04-09 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 55,23 | +2,87% | 4 491 756 |
22-04-24 | 53,69 | +4,90% | 4 184 429 |
19-04-24 | 51,18 | -0,72% | 2 849 877 |
18-04-24 | 51,55 | -0,27% | 2 377 059 |
17-04-24 | 51,69 | +1,33% | 4 455 011 |
slotkoers Shanghai S.E., 23 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,87% | 1,58 mld. | |
+26,97% | 659 mld. | |
+27,10% | 557 mld. | |
-5,23% | 359 mld. | |
+16,66% | 322 mld. | |
+9,44% | 297 mld. | |
+6,04% | 215 mld. | |
+5,33% | 210 mld. | |
-6,05% | 200 mld. | |
-8,56% | 149 mld. |